Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2013-11-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2076-2607/1/1/100 |
| _version_ | 1818041575896252416 |
|---|---|
| author | Volker Sandig Udo Reichl Verena Lohr Yvonne Genzel Ingo Jordan |
| author_facet | Volker Sandig Udo Reichl Verena Lohr Yvonne Genzel Ingo Jordan |
| author_sort | Volker Sandig |
| collection | DOAJ |
| description | The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes for different vaccine viruses. One of the processes investigated in greater detail was developed for modified vaccinia virus Ankara (MVA). MVA is highly attenuated for human recipients and an efficient vector for reactogenic expression of foreign genes. Because direct cell-to-cell spread is one important mechanism for vaccinia virus replication, cultivation of MVA in bioreactors is facilitated if cell aggregates are induced after infection. This dependency may be the mechanism behind our observation that a novel viral genotype (MVA-CR) accumulates with serial passage in suspension cultures. Sequencing of a major part of the genomic DNA of the new strain revealed point mutations in three genes. We hypothesize that these changes confer an advantage because they may allow a greater fraction of MVA-CR viruses to escape the host cells for infection of distant targets. Production and purification of MVA-based vaccines may be simplified by this combination of designed avian cell line, chemically defined media and the novel virus strain. |
| first_indexed | 2024-12-10T08:32:37Z |
| format | Article |
| id | doaj.art-825292b1b41540fa85509e2b13dfbcb7 |
| institution | Directory Open Access Journal |
| issn | 2076-2607 |
| language | English |
| last_indexed | 2024-12-10T08:32:37Z |
| publishDate | 2013-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Microorganisms |
| spelling | doaj.art-825292b1b41540fa85509e2b13dfbcb72022-12-22T01:56:03ZengMDPI AGMicroorganisms2076-26072013-11-011110012110.3390/microorganisms1010100Elements in the Development of a Production Process for Modified Vaccinia Virus AnkaraVolker SandigUdo ReichlVerena LohrYvonne GenzelIngo JordanThe production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicken eggs. To replace this logistically demanding substrate, we created continuous anatine suspension cell lines (CR and CR.pIX), developed chemically-defined media, and established production processes for different vaccine viruses. One of the processes investigated in greater detail was developed for modified vaccinia virus Ankara (MVA). MVA is highly attenuated for human recipients and an efficient vector for reactogenic expression of foreign genes. Because direct cell-to-cell spread is one important mechanism for vaccinia virus replication, cultivation of MVA in bioreactors is facilitated if cell aggregates are induced after infection. This dependency may be the mechanism behind our observation that a novel viral genotype (MVA-CR) accumulates with serial passage in suspension cultures. Sequencing of a major part of the genomic DNA of the new strain revealed point mutations in three genes. We hypothesize that these changes confer an advantage because they may allow a greater fraction of MVA-CR viruses to escape the host cells for infection of distant targets. Production and purification of MVA-based vaccines may be simplified by this combination of designed avian cell line, chemically defined media and the novel virus strain.http://www.mdpi.com/2076-2607/1/1/100AGE1.CR.pImuscovy duck continuous cell linemodified vaccinia virus AnkaraMVA (modified vaccinia virus Ankara) |
| spellingShingle | Volker Sandig Udo Reichl Verena Lohr Yvonne Genzel Ingo Jordan Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara Microorganisms AGE1.CR.pI muscovy duck continuous cell line modified vaccinia virus Ankara MVA (modified vaccinia virus Ankara) |
| title | Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara |
| title_full | Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara |
| title_fullStr | Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara |
| title_full_unstemmed | Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara |
| title_short | Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara |
| title_sort | elements in the development of a production process for modified vaccinia virus ankara |
| topic | AGE1.CR.pI muscovy duck continuous cell line modified vaccinia virus Ankara MVA (modified vaccinia virus Ankara) |
| url | http://www.mdpi.com/2076-2607/1/1/100 |
| work_keys_str_mv | AT volkersandig elementsinthedevelopmentofaproductionprocessformodifiedvacciniavirusankara AT udoreichl elementsinthedevelopmentofaproductionprocessformodifiedvacciniavirusankara AT verenalohr elementsinthedevelopmentofaproductionprocessformodifiedvacciniavirusankara AT yvonnegenzel elementsinthedevelopmentofaproductionprocessformodifiedvacciniavirusankara AT ingojordan elementsinthedevelopmentofaproductionprocessformodifiedvacciniavirusankara |